antimony has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atabek, ME; Pirgon, O; Unal, E | 1 |
| Dumas, ML; Dumas, R; Morin, D; Valette, H | 1 |
2 other study(ies) available for antimony and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes.
Topics: Adolescent; Antimony; Antiprotozoal Agents; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Knee; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2006 |
[Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].
Topics: Acute Kidney Injury; Antimony; Antiprotozoal Agents; Child, Preschool; Diabetes Mellitus, Type 1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Nephrotic Syndrome; Pentamidine | 1991 |